Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes
References (24)
- et al.
Peculiar behaviour of rabbit thymocytes in interaction with liposomes of different compositions shown by fluorescence polarization studies, lipid analysis, uptake of vesicle-entrapped carboxyfluorescein
Biochim.Biophys.Acta
(1982) - et al.
Liposome-mediated delivery of ribosome inactivating proteins to cells in vitro
Biochim.Biophys.Acta
(1982) - et al.
Human tumor necrosis factor
Production, purification and characterization.J.Biol.Chem
(1985) Lymphotoxin redux
Immunol.Today
(1985)- et al.
Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line
J.Biol.Chem
(1985) - et al.
Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes
J.Immunol
(1981) - et al.
Studies on the mechanism of natural killer cytotoxicity
II.Co-culture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.J.Immunol
(1983) - et al.
YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity
Proc.Natl.Acad.Sci.USA
(1983) - et al.
Studies on the mechanism of natural killer cellmediated cytotoxicity
V.Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat ef f ector cells stimulated with mycoplasma-free cell lines.J.Immunol
(1984) - et al.
Analysis of the mechanism of NK resistance operating in two variants of YAC-1 in the natural killer cytotoxic factor system
Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside
Biochemistry
(1981)
The interaction of lipid vesicles (liposomes) with cultured cells and their use as carriers for drugs and macromolecules
Cited by (1)
NK cell phenotypic and functional heterogeneities and molecular mechanisms of cytotoxicity
2014, Critical Reviews in Oncogenesis
This work was supported by grant R 93-112 from the Netherlands Organization for the Advancement of Pure Research (R.C.R.) and by grants CA 09120 (S.C.W.and S.S.G.) and CA 35791 (B.B.) from the National Cancer Institute.
- *
Dr.R.C.Roozemond, Department of Histology and Cell Biology, University of Amsterdam, Academical Medical Center, Meibergdreef 15,1105 AZ Amsterdam, The Netherlands
Copyright © 1987 Gustav Fischer Verlag · Stuttgart · New York. Published by Elsevier GmbH All rights reserved.